KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) Revenue (2016 - 2026)

Insulet filings provide 16 years of Revenue readings, the most recent being $783.8 million for Q4 2025.

  • On a quarterly basis, Revenue rose 31.18% to $783.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 billion, a 30.73% increase, with the full-year FY2025 number at $2.7 billion, up 30.73% from a year prior.
  • Revenue hit $783.8 million in Q4 2025 for Insulet, up from $706.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $783.8 million in Q4 2025 to a low of $247.0 million in Q1 2022.
  • Median Revenue over the past 5 years was $414.6 million (2023), compared with a mean of $440.6 million.
  • Biggest five-year swings in Revenue: decreased 1.0% in 2022 and later skyrocketed 44.98% in 2023.
  • Insulet's Revenue stood at $307.7 million in 2021, then rose by 20.15% to $369.7 million in 2022, then soared by 37.9% to $509.8 million in 2023, then grew by 17.2% to $597.5 million in 2024, then soared by 31.18% to $783.8 million in 2025.
  • The last three reported values for Revenue were $783.8 million (Q4 2025), $706.3 million (Q3 2025), and $649.1 million (Q2 2025) per Business Quant data.